Product image of Monopost Unidose (Latanoprost) supplied by GNH India

Monopost Unidose

Active Ingredient:
Latanoprost
Origin:
EU

Monopost Unidose (Latanoprost)

Latanoprost, the active ingredient in Monopost Unidose, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for primary open‑angle glaucoma and ocular hypertension in adult patients.
GNH India supplies Monopost Unidose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratoires Thea

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Latanoprost belongs to the prostaglandin analog class and is used to manage conditions that require reduction of intra‑ocular pressure.
  • Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage and preserve visual field.
  • Ocular hypertension: lowers elevated eye pressure to prevent progression to glaucoma.

How It Works

  • Latanoprost is a prostaglandin F2α analogue that binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. The increased outflow reduces intra‑ocular pressure, thereby helping to protect the optic nerve from pressure‑related damage.

Side Effects

Latanoprost may cause a range of ocular and systemic reactions.

Common Side Effects

  • Eye redness or hyperemia: mild conjunctival injection after instillation.
  • Increased eyelash growth: longer, thicker lashes may develop.
  • Iris pigmentation change: gradual darkening of the iris color.
  • Eye irritation or foreign‑body sensation: transient discomfort.

Serious or Rare Side Effects

  • Uveitis or intraocular inflammation: requires immediate ophthalmic evaluation.
  • Macular edema: rare swelling of the central retina that can affect vision.
  • Severe allergic reaction: including swelling, itching, or rash around the eye.
  • Vision loss: abrupt decrease in visual acuity warrants urgent care.
  • Persistent eye pain: may indicate a serious ocular condition.

Precautions & Warnings

  • Before using Latanoprost, patients and clinicians should consider several safety measures.
  • Monitor IOP: schedule regular intra‑ocular pressure checks to assess efficacy.
  • Assess for ocular infection: avoid use if active conjunctivitis or keratitis is present.
  • Avoid use in patients with active intraocular inflammation: may exacerbate the condition.
  • Caution in patients with a history of uveitis: increased risk of flare‑ups.
  • Pregnancy: safety category unknown; prescribe only if potential benefit justifies the risk.
  • Store at below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ocular or systemic agents, influencing pressure control or tolerability.

Major Interactions (Avoid)

  • Concomitant prostaglandin analogs: additive IOP lowering may cause excessive reduction.
  • Non‑steroidal anti‑inflammatory eye drops: may diminish Latanoprost efficacy.
  • Systemic carbonic anhydrase inhibitors: potential interference with intra‑ocular pressure regulation.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: combined effect may lead to overly low IOP; monitor pressure.
  • Alpha‑agonist eye drops: possible additive pressure‑lowering; adjust therapy as needed.
  • Systemic antihistamines: may cause dry eye; assess ocular comfort regularly.

Frequently Asked Questions

Monopost Unidose contains latanoprost, a prostaglandin analog indicated for lowering intra‑ocular pressure in adults with primary open‑angle glaucoma and ocular hypertension. By reducing pressure, it helps protect the optic nerve and preserve visual function.

Latanoprost mimics prostaglandin F2α and activates FP receptors in the ciliary body. This activation increases uveoscleral outflow of aqueous humor, allowing fluid to drain more efficiently from the eye and thereby decreasing intra‑ocular pressure.

The dosing regimen for Monopost Unidose is determined by the prescribing ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and schedule must follow the prescriber’s instructions.

The pregnancy safety category for latanoprost is unknown. It should be used during pregnancy only if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as limited data are available.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost is a first‑line prostaglandin analog that often provides greater IOP reduction than beta‑blockers or carbonic anhydrase inhibitors. It is administered once daily and has a favorable dosing convenience, though individual response and side‑effect profiles may differ among patients.

Monopost Unidose should be stored at temperatures below 25 °C, in its original container, protected from light and moisture. Do not freeze the product, and keep it out of reach of children.

The medication is supplied as an ophthalmic solution. The patient instills one drop into the prescribed eye(s) in the evening, avoiding contact with the tip of the bottle and washing hands before and after application.

Serious risks include uveitis, macular edema, severe allergic reactions, and sudden vision loss. Any signs of intraocular inflammation, rapid visual changes, or persistent eye pain require immediate medical attention.

Patients with active intra‑ocular inflammation, known hypersensitivity to latanoprost or any component of the formulation, or those who have experienced severe adverse reactions to prostaglandin analogs should avoid using Monopost Unidose. A healthcare professional should evaluate suitability before initiation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT